Kenneth A Burdick Centene Corp (CNC) insider trading activity

Kenneth A Burdick is Director of CENTENE CORP. Currently has a direct ownership of 362,417 shares of CNC, which is worth approximately $23.5 Million. The most recent transaction as insider was on Dec 31, 2024, when has been sold 497 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 362K

0.14% 3M change

2.65% 12M change

Total Value Held $23.5 Million

Kenneth A Burdick Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2024	BUY Grant, award, or other acquisition	-	497 Added 0.14%	362,417 Common Stock
Sep 30 2024	BUY Grant, award, or other acquisition	-	402 Added 0.11%	361,920 Common Stock
Jun 30 2024	BUY Grant, award, or other acquisition	-	452 Added 0.12%	361,518 Common Stock
May 14 2024	BUY Grant, award, or other acquisition	-	2,916 Added 0.8%	361,066 Common Stock
Mar 31 2024	BUY Grant, award, or other acquisition	-	388 Added 0.11%	358,150 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	$2,449,198 $74.07 p/Share	33,066 Reduced 8.46%	357,762 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	18,563 Added 4.53%	390,828 Common Stock
Dec 31 2023	BUY Grant, award, or other acquisition	-	485 Added 0.13%	372,265 Common Stock
Sep 30 2023	BUY Grant, award, or other acquisition	-	526 Added 0.14%	371,780 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	524 Added 0.14%	371,254 Common Stock
May 10 2023	BUY Grant, award, or other acquisition	-	2,947 Added 0.79%	370,729 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	493 Added 0.13%	367,782 Common Stock
Feb 07 2023	SELL Payment of exercise price or tax liability	$2,124,761 $71.01 p/Share	29,922 Reduced 7.53%	367,289 Common Stock
Feb 07 2023	BUY Grant, award, or other acquisition	-	1,901 Added 0.48%	397,211 Common Stock
Dec 31 2022	BUY Grant, award, or other acquisition	-	428 Added 0.11%	395,310 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	366 Added 0.09%	394,881 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	376 Added 0.1%	394,515 Common Stock
Apr 26 2022	BUY Grant, award, or other acquisition	-	2,323 Added 0.59%	394,139 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	$31,250 $82.02 p/Share	381 Added 0.1%	391,816 Common Stock
Feb 07 2022	BUY Grant, award, or other acquisition	-	1,100 Added 0.28%	391,435 Common Stock
Nov 09 2020	SELL Open market or private sale	$2,455,600 $70.16 p/Share	35,000 Reduced 4.17%	803,386 Common Stock
Nov 02 2020	SELL Open market or private sale	$2,170,700 $62.02 p/Share	35,000 Reduced 4.01%	838,386 Common Stock
Oct 05 2020	SELL Open market or private sale	$2,170,000 $62.0 p/Share	35,000 Reduced 3.85%	873,386 Common Stock

Also insider at

FHN

FIRST HORIZON CORP Financial Services

Director

LFST

LifeStance Health Group, Inc. Healthcare

Chief Executive Officer

KAB